Background: By supporting the production of domestic substitutes for essential medicines listed in Mongolia’s national drug policy, pharmaceutical companies are enabled to ensure product quality assurance, conduct safety monitoring and research, and carry out quality control and certification of medicines. Therefore, ongoing quality assessment is essential to ensure that domestically manufactured medicines meet established standards before they can replace imported alternatives. This study seeks to assess whether the quality parameters of both locally produced and imported 500 mg Chloramphenicol capsules available in the Mongolian pharmaceutical market conform to the requirements of the Mongolian National Pharmacopoeia. Aim: To compare and study the quality parameters of certain domestically manufactured and imported chloramphenicol capsule formulations in accordance with pharmacopoeial standards Materials and Methods: This study examined four types of 0.5 g Chloramphenicol capsules: three domestically produced (X1, X2, X4) and one imported (X3). The evaluation included tests for identification, average weight, weight variation, dissolution, disintegration, thin-layer chromatography (TLC), assay, high-performance liquid chromatography (HPLC), and microbiological analysis, following the standards outlined in the Mongolian National Pharmacopoeia 2011 (MNP 2011), United States Pharmacopeia 39 (USP 39), Japanese Pharmacopoeia 18 (JP 18), and Chinese Pharmacopoeia 2020 (ChP 2020). Statistical analysis was performed using SPSS version 22.0. Result: The purity analysis of samples X1, X2, X3, and X4 indicated that all met the applicable standards. Among them, X1 and X3 complied with pharmacopoeial requirements for identification, weight variation, dissolution, active ingredient assay, and thin-layer chromatography (TLC). In contrast, X4 failed the identification test and had a low active ingredient content, while both X2 and X4 exhibited inadequate dissolution, suggesting non-compliance with standard requirements. Furthermore, high-performance liquid chromatography (HPLC) analysis based on USP criteria revealed that neither X1 nor X3 met the specified limits. Conclusion Among the four Chloramphenicol capsule samples analyzed, only X1 and X3 met the pharmacopoeial standards. The non-compliance of X2 and X4 underscores the importance of continuous monitoring and quality assessment of domestically manufactured pharmaceuticals.

Background: Dysregulation of inflammation underpins chronic cardiovascular, metabolic, neurodegenerative, and neoplastic conditions. Traditional medicine has long utilized medicinal plants to alleviate and treat systemic inflammation. Specifically, Rhodiola rosea L. and Rhodiola quadrifida (Pall.) Fisch. & C.A.Mey. possess anti-inflammatory, antitumor, antioxidant, and anti-angiogenic properties. Saposhnikovia divaricata (Turcz.) Schischk. has been shown to exert anti-inflammatory effects, support musculoskeletal function, and enhance tissue regeneration. Furthermore, Salsola laricifolia Litv. has been studied for its antioxidant, immunomodulatory, and anti-inflammatory activities. Although the individual anti-inflammatory, antioxidant, and antitumor activities of these plants are established, research evaluating the combined effect of their combined extract remains scarce, providing the rationale for this study. Aim: To evaluate the in vitro effects of a combined extract derived from these medicinal plants on the expression of selected pro-inflammatory cytokines. Materials and Methods: A dry combined extract consisting of Rhodiola rosea, Rhodiola quadrifida, Salsola laricifolia, and Saposhnikovia divaricata was prepared at the Chemistry and Technology Sector of the Institute of Pharmaceutical Research, Monos Group. An in vitro inflammation model was established using murine RAW264.7 macrophage-like cells stimulated with lipopolysaccharide (LPS, 100 ng/mL). Cell viability was assessed using the CCK-8 assay, while the output of pro-inflammatory cytokines TNF-α and IL-6 was measured via Enzyme-Linked Immunosorbent Assay (ELISA). Statistical analysis was performed using one-way ANOVA. Result: The combined plant extract demonstrated no cytotoxic effects on RAW264.7 cells across the tested concentration range. In LPS-stimulated RAW264.7 macrophages, the composite extract dose-dependently and significantly suppressed the production of the pro-inflammatory cytokines TNF-α (p<0.001) and IL-6 (p<0.0001). Conclusion 1. The combined extract of Saposhnikovia divaricata, Rhodiola rosea, Rhodiola quadrifida, and Salsola laricifolia exhibited no cytotoxicity in vitro within the range of 50–400 µg/mL. 2. The combined herbal extract significantly suppressed the production of pro-inflammatory cytokines TNF-α (p<0.01) and IL-6 (p<0.001) in LPS-induced RAW264.7 macrophages in a concentration-dependent manner.

Background: Medicinal herbs have been used in traditional medicine to treat systemic inflammatory disease for many years. For instance, Rhodiola rosea L extracts were used to enhance behavioural stresses for improving fatigue and depression. Gallic acid, found in Rhodiola rosea L and Rhodiola quidrifida is, a natural polyphenol, exhibits multiple therapeutic activities, including anti-inflammatory, anti-cancer, antioxidant, and anti-angiogenic effects. Saposhnikovia divaricate (its ethanol extract mainly) notified to support function of musculoskeletal tissue and to enhance tissue regeneration by its anti-inflammatory effect. The Salsola laricifolia L has been studied for its strong antioxidant activity, improve immune function, boost energy, and exhibit anti-inflammatory effects. This study allowed us to screen anti-inflammatory effects of medicinal plants and future therapeutic possibility. Aim: To study the content of phenolic compounds (gallic acid) in the composition of complex products of plants widely used in Mongolian traditional medicine, which have been found to have biological activity of the extracts Materials and Methods: The herbal extract was extracted from Rhodiola rosea L, Saposhnikovia divaricata (Tuscz) Schischk, Rhodiola quidrifida Pall.Fisch, Salsola laricifolia Turcz.ex Litv in laboratory of the Drug Research Institute of Monos Group, Mongolia. We used solvents for HPLC grade was used to identify the bioactive components that Gallic acid in the compound plant extract. : Results: The bioactive compounds in each of the Rhodiola rosea L, Rhodiola quadrifida Pall.Fisch and four medicinal plant extracts were identified using HPLC, confirming the presence of Gallic acid. Conclusion Our research results showed that the quantitative content of Gallic acid in the composite plant extract was high, at 1.02%.

Sleep fulfills the vital physiological needs of the human body. However, 45 percent of the world’s population suffers from sleep problems.
In this article, Sugmel 3 tan /prescription/ widely used in traditional medicine for insomnia was selected and biologically active compounds and pharmacological activities of the plants included in the prescription were reviewed. Essential oils from fruits of Amomum kravanh Pierre ex Gagnep and Cuminum cyminum L. are considered to relax the body and mind to improve a night of sleep. Pharmacological and clinical studies of piperine isolated from Piper longum L. fruits demonstrated that the compound possessed anti-depression-like activity and cognitive enhancing effect.

Background: Diseases of the digestive system are one of the leading causes of global morbidity, and liver disease is the leading cause, accounting for 52.34% of 100,000 population in Asian countries. In Mongolia, cirrhosis accounted for 32.4% of all liver diseases in 2019.
In traditional medical treatment, liver cirrhosis is included in the scope of chronic diseases and compared with liver’s smug po disease for treatment. In this study, we aimed to clarify the mechanism of action of Tumrinn talkh-7, which is widely used in the treatment of liver diseases, especially in the treatment of liver diseases. Materials and methods: In our study, we used the book named “Oral Instruction Tantra” as main reference material and for research methods, we used the checklist method to list relevant information about the pathogenesis of liver smug po and Tumriin Talkh-7 traditional drug from the literature, so as to provide preconditions for further analysis. The pathogenesis of liver smug po and the action mechanism of Tumriin Talkh-7 were analyzed by theoretical analysis methods and the analysis-synthesis method was used to summarize the analysis results. Results: Due to the hot conditions, the blood heat will increase occur. Due to the cold conditions, food absorption is impaired bad blood is formed in the liver. This is how Smug po disease occurs. Tumriin talkh-7 traditional drugs should be analyzed in relation to the transformation of liver smug po disease.
Iron dust is treating heat liver smug po removed.
Calcitu-CaCO3 is clear phlegm heat.
Dracocephallum foetidum Bge. is cures stomach and liver heat.
Inula helenium L. is equable and cures all liver Smug po diseases.
Saussurea lappa L. is sharp, warm nature, regulating wind-blood disorder.
Trogopterus xanthipes mine Edwards is treating old liver disease.
Carthamus tinctorius L. is saffron cures all liver diseases. Conclusions Pathological blood caused by cold and heat factors leads to liver smug po disease. Tumriin Talkh-7 is a cold drug with the effect of treating hot liver smug po disease.

Introduction: Since 1993, the Inula helenium L. plant has been planted in the production area (Bulgan Province, Dashinchilen Sum) of the Traditional Hatchery Science and Production Corporation’s medicinal plant introduction and cultivation experience. At the Drug Research Institute, there is also a botanical institute for medicinal plants where it is grown. In traditional Mongolian medicine, the roots and rhizomes of Inula helenium L. are used to reduce inflammation, boost immunity, enhance hunger, and improve intestinal motility. Inula helenium L. roots and rhizomes contain biologically active compounds such as monoterpenes, sesquiterpenes, phenols, flavonoids, and polysaccharides. Methods: The roots and rhizomes of Inula helenium L. were extracted with water and 70% ethanol at the following ratios 1:10 (2% of WAC), 1:8, and 1:6 by partial maceration at 700C for 2 hours each, extracted and concentrated. The dry extract was obtained by the spray drying procedure. High-performance liquid chromatography for determining the content of alantolactone, thin-layer chromatography for qualitative analysis. Spectrophotometer for determining the content of polyphenolic compounds, colored compounds with Folin-Ciocalteu reagent for qualitative analysis. Spectrophotometer for determining the content of inulin, and colored compounds with phenol and sulfuric acid solutions for qualitative analysis. Conclusion In determining the content of polyphenolic compounds, inulin, and alantolactone in the dry extract taken from the roots and rhizomes of cultivated Inula helenium L., the content of polyphenolic compound in dry extract A was 2.50±0.08%, and alantolactone was 1.39±0.11% in the raw material of the plant, while B dry the extract had a high concentration of inulin of 58.51±0.66%.

The Jerusalem Artichoke (JA) (Helianthus tuberosus L.) is an annual plant native to North America and widely distributed in Europe and Central Asia. The tuber of JA contains 80% water, 15% polysaccharide (Inulin etc.), 2% protein, and a small amount of starch and fat. Inulin is a polysaccharide that is widely used as a prebiotic, fat substitute, and sugar substitute. This substance has high biological activity and is contained in large quantities.
The purpose of this study was to standardize the quality and safety of dried tubers of JA. Standardization includes parameters such as microscopic analysis, identification, quantification, validation of methods following the guidelines issued by ICH guidelines, and quality, including safety analysis (appearance, moisture, mechanical impurities, heavy metals, microbiological purity).
The content of inulin was 64.17±1.25%. The mean relative standard deviation of method validation (RMS%) was 1.27%, 1.18%, 1.22%, and the relative mean standard deviation (RMS) of method precision was 1.94%. The specific absorbance was 307 nm. The correlation coefficient R2=0.9998 was obtained for the reference curve of the standard substance. The detection limit of the method was 2.64 μg/ml, and the detection limit was 7.99 μg/ml.
The method mentioned above has been confirmed to be suitable for the quantitative determination of inulin in the tuber of JA. Moreover, Microbiological purity and heavy metal requirements are met.

Background: The high-performance liquid chromatography (HPLC) method was developed to select salidroside in tablet formulation dietary supplements, raw material containing other components. Further, the proposed method was validated for linearity, precision (system precision, method precision, intermediate or inter-day precision), and accuracy, stability in analytical solution, syst em suitability, and ruggedness. The developed method exhibited the best results in terms of the validation above parameters. The other components and additives did not interfere with their determinations. The method was found to be selective, simple, economical, accurate, reproducible, rapid, and reliable for routine estimation purposes of salidroside in golden root dry extract. The goal of this study was to develop the validation method of salidroside in the dietary supplement. Material and Methods: The Rhodiola rosae L. dry extract was supplied Arshin Co.ltd in People’s Republic of China. The standard salidroside was supplied from Sigma Aldrich Co Ltd. We used solvents for HPLC grade (methanol, acetonitrile). Chromatographic conditions: A gradient HPLC (Shimadzu CBM20AD) with serial dual plunger pump; analytical column: Shimadzu GIST С18 150 x 4.6 mm, particle size 5 μm; flow rate: 1 ml/min; column temperature: 400C, detection: UV 275 nm. Chromatographic procedure: 20 μl of the mixed standard preparation and assay (sample) preparation were separately injected into the chromatography, the chromatograms were recorded, and the responses for the major peaks were measured. The run time was approximately 15 minutes. Results The calibration curves for the salidroside were made by plotting the peak area versus the concentration for each analyte using regression analysis. Each calibration curve was obtained using six levels of concentrations in the range of 100-800 µg/mL. The linear correlation coefficient (r2=1) for all calibration curves was higher than 1 for all analytes. The LOD and LOQ for salidroside were golden root dry extract in 8.788 µg/mL and 26.61 µg/mL, respectively. Accuracy and precision were assessed by analyzing five samples independently prepared at low, middle, and high concentrations. The RSD values of repeatability and intermediate precision were below 1.12%, 1.19 and 1.79%. The accuracy remains between 91 to 109%. The resulting accuracy data were satisfactory for the quantitative analysis of salidroside in golden root dry extract. This article presents a simple, accurate, reproducible, and thoroughly validated HPLC-based method for qualitative and quantitative analysis of salidroside, as part of the quality assessment of golden root dry extract.

Myocardial infarction (Ml) is necrosis and death of heart muscle secondary to ischemia and acute coronary artery thrombosis. Ml, commonly known as a heart attack, happens when the oxygen rich blood flow to a part of the heart muscle is blocked for a prolonged period, causing damage or death to the heart tissue. This blockage is most often caused by a buildup of fat, cholesterol, and other substances, which form a plaque in the coronary arteries. Furthermore, patients with cancer constitute a high-risk population for cardiovascular disease and as of the last 5 years, 50% of patients with cardiovascular disease have been diagnosed with cancer, according to World Health Organization. The provision of complete insight into Ml complications along with designing ajpreventive program against Ml seems necessary. The use of medications has been practiced over the years for the prevention of HF. However, some of these medications produce adverse effects and due to high cost are not easily available to every patient. Over the past decades, there has been a significant rise in the use of herbal supplements based on traditional medicine to prevent, avoid, and/or treat different conditions, including cardiovascular disease; this rise results from a natural source, efficiency with few or no adverse effects and low cost. In vivo models of heart failure (HF) and myocardial infarction (Ml) are essential for understanding the pathophysiology of these conditions and for developing new treatments.
These models typically involve inducing heart failure or myocardial infarction in animals, such as rodents to study disease mechanisms and evaluate potential therapies.
In this review, we discuss the most common preclinical models of Ml currently employed in cardiovascular research. Among them, Ml induced heart failure is a method of ligation of the left anterior descending artery of coronary an experimental animal. Its physiological relevance, cost-effective, uncomplicated, and suitable method for evaluating research results. The rat model of myocardial infarction offers numerous advantages that make it a valuable tool for cardiovascular research.

Introduction: The Five Medicinal Herb Soak Therapy, as described in the 23rd chapter of “The Secret Quintessential Instructions on the Eight Branches of the Ambrosia Essence Tantra,” a key text in traditional medicine, is noted for its therapeutic applications. It is recommended for conditions such as joint stiffness, tumors, acute and chronic wound swelling, sores, abscesses, hunchback, muscle rheumatism, anthrax, scattered heat and wind disorders. The Five Medicinal Herb Soak consists of Ledum palustre L., Juniperus pseudosabia Fisch.Et M., Myricaria alopecuroides Schrenk., Ephedra Przewalskii Stapf., and Artemisia frigida Willd. This therapy is widely practiced in Mongolia, China, the Inner Mongolia Autonomous Region, the Tibetan Autonomous Region, the Qinghai Province, and the Gansu Province. This clinical observational study review aims to predict treatment outcomes, establish treatment guidelines, and facilitate the development of other pharmaceutical forms. It is anticipated that this review will serve as a scientific reference for the application of the Five Medicinal Herb Soak Therapy. Objective: The objective of this review is to analyze and synthesize clinical studies on the Five Medicinal Herb Soak Therapy. Methods: Keywords “五味甘露” (Wu wei gan lu), “Tibetan medicine five-flavor Manna” were used to search for relevant research articles and theses in biomedical databases, including PubMed (https://pubmed.ncbi. nlm.nih.gov/) and the China National Knowledge Infrastructure CNKI (https://www.cnki.net/). The collected data were systematically analyzed and reviewed. Conclusion The Five Medicinal Herb Soak Therapy demonstrates significant therapeutic value in treating conditions such as gout, rheumatic joint inflammations, digestive disorders, female reproductive system diseases, spinal herniation, arthritis, varicose veins, and scurvy. Integrating this therapy with Mongolian, Tibetan, Chinese, and European medical practices can enhance treatment efficacy by reducing treatment duration, alleviating symptoms, and preventing recurrence. Furthermore, developing more efficient pharmaceutical forms of the Five Medicinal Herb Soak could improve its effectiveness and reduce potential side effects.